Icon

ERAXIS (nda021632)- (50MG/VIAL,100MG/VIAL)

ANIDULAFUNGIN VICURON HOLDINGS
50MG/VIAL,100MG/VIAL
No No
2022-Jun-13 2011-Feb-17
None None
None No
ERAXIS is an echinocandin antifungal indicated for the treatment of the following infections: Candidemia and other forms of Candida infections (intra-abdominal abscess and peritonitis) in adults and pediatric patients (1 month of age and older) Esophageal candidiasis in adults.
0 0 0
Total Other Developers None
Drugs with Suitability No
50MG/VIAL ** ** - - -
100MG/VIAL ** ** - - -
NDA Sales Available Total Generic Sales Available
Yes 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.